{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:53:21Z","timestamp":1787792001427,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.prp.2023.154766","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T20:54:53Z","timestamp":1692046493000},"page":"154766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Astragaloside IV antagonizes the malignant progression of breast cancer induced by macrophage M2 polarization through the TGF-\u03b2-regulated Akt\/Foxo1 pathway"],"prefix":"10.1016","volume":"249","author":[{"given":"Yanqin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqi","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3612-7689","authenticated-orcid":false,"given":"Shu","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.prp.2023.154766_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102569","article-title":"Breast cancer-epidemiology, classification, pathogenesis and treatment (review of literature)","volume":"14","author":"Smolarz","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.prp.2023.154766_bib2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2023.154766_bib3","doi-asserted-by":"crossref","first-page":"9258396","DOI":"10.1155\/2020\/9258396","article-title":"Signal transduction pathways in breast cancer: the important role of PI3K\/Akt\/mTOR","volume":"2020","author":"Ortega","year":"2020","journal-title":"J. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.154766_bib4","first-page":"165","article-title":"Breast cancer: Actual methods of treatment and future trends","volume":"19","author":"Murawa","year":"2014","journal-title":"Rep. Pr. Oncol. Radio."},{"issue":"1","key":"10.1016\/j.prp.2023.154766_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7150\/jca.49692","article-title":"Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications","volume":"12","author":"Zhu","year":"2021","journal-title":"J. Cancer"},{"issue":"13","key":"10.1016\/j.prp.2023.154766_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154766_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642285","article-title":"Mechanisms of macrophage plasticity in the tumor environment: manipulating activation state to improve outcomes","volume":"12","author":"Ricketts","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2023.154766_bib8","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.2147\/DDDT.S272355","article-title":"Astragaloside IV: an effective drug for the treatment of cardiovascular diseases","volume":"14","author":"Tan","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.prp.2023.154766_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112797","article-title":"Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation: Status and prospect","volume":"258","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.prp.2023.154766_bib10","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/fsn3.1154","article-title":"Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K\/AKT\/mTOR signaling pathway","volume":"7","author":"Zhang","year":"2019","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.prp.2023.154766_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104272","article-title":"QiShenYiQi Pills(\u00ae) ameliorates ischemia\/reperfusion-induced myocardial fibrosis involving RP S19-mediated TGF\u03b21\/Smads signaling pathway","volume":"146","author":"Zheng","year":"2019","journal-title":"Pharm. Res"},{"key":"10.1016\/j.prp.2023.154766_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109387","article-title":"Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-\u03b21\/Smad3 signaling","volume":"119","author":"Li","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"7","key":"10.1016\/j.prp.2023.154766_bib13","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/ptr.6057","article-title":"Astragaloside IV inhibits TGF-\u03b21-induced epithelial-mesenchymal transition through inhibition of the PI3K\/Akt\/NF-\u03baB pathway in gastric cancer cells","volume":"32","author":"Zhu","year":"2018","journal-title":"Phytother. Res"},{"issue":"6","key":"10.1016\/j.prp.2023.154766_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114006119","article-title":"miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression","volume":"119","author":"Ma","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.prp.2023.154766_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00991-2","article-title":"Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer","volume":"13","author":"Zhao","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154766_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1447-y","article-title":"MSC-secreted TGF-\u03b2 regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt\/FoxO1 pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154766_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbrc.2016.09.153","article-title":"TGF-\u03b2-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation","volume":"480","author":"Kurebayashi","year":"2016","journal-title":"Biochem Biophys. Res Commun."},{"issue":"3","key":"10.1016\/j.prp.2023.154766_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/imt-2016-0135","article-title":"Tumor-associated macrophages: implications in cancer immunotherapy","volume":"9","author":"Petty","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.prp.2023.154766_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Ngambenjawong","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.prp.2023.154766_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.154766_bib21","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4846","article-title":"Molecular mechanisms of astragaloside\u2011IV in cancer therapy (Review)","volume":"47","author":"Chen","year":"2021","journal-title":"Int J. Mol. Med"},{"issue":"1","key":"10.1016\/j.prp.2023.154766_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11418-020-01469-8","article-title":"Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1","volume":"75","author":"Hu","year":"2021","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.prp.2023.154766_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.molimm.2020.11.014","article-title":"Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis","volume":"130","author":"Wang","year":"2021","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.154766_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-0878-0","article-title":"Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling","volume":"37","author":"Xu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.prp.2023.154766_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.791272","article-title":"Transforming Growth Factor-Beta (TGF-\u03b2) Signaling in Cancer-A Betrayal Within","volume":"13","author":"Baba","year":"2022","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.prp.2023.154766_bib26","doi-asserted-by":"crossref","first-page":"a003277","DOI":"10.1101\/cshperspect.a003277","article-title":"TGF-beta biology in mammary development and breast cancer","volume":"3","author":"Moses","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.prp.2023.154766_bib27","article-title":"Astragaloside IV inhibits cell invasion and metastasis in vulvar squamous cell carcinoma through the TGF-\u03b21\/FAK\/AKT signaling pathway","author":"Zhao","year":"2021","journal-title":"Ginekol. Pol."},{"issue":"32","key":"10.1016\/j.prp.2023.154766_bib28","doi-asserted-by":"crossref","first-page":"52294","DOI":"10.18632\/oncotarget.10561","article-title":"TGF-\u03b2 induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2023.154766_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2172-13-31","article-title":"TGF\u03b2 signaling plays a critical role in promoting alternative macrophage activation","volume":"13","author":"Gong","year":"2012","journal-title":"BMC Immunol."},{"issue":"20","key":"10.1016\/j.prp.2023.154766_bib30","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1111\/febs.14201","article-title":"TGF-\u03b21 targets Smad, p38 MAPK, and PI3K\/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells","volume":"284","author":"Rodr\u00edguez-Garc\u00eda","year":"2017","journal-title":"FEBS J."},{"issue":"7","key":"10.1016\/j.prp.2023.154766_bib31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.7150\/ijbs.20052","article-title":"FOXO signaling pathways as therapeutic targets in cancer","volume":"13","author":"Farhan","year":"2017","journal-title":"Int J. Biol. Sci."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823004661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823004661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:38:27Z","timestamp":1777559907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823004661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":31,"alternative-id":["S0344033823004661"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154766","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragaloside IV antagonizes the malignant progression of breast cancer induced by macrophage M2 polarization through the TGF-\u03b2-regulated Akt\/Foxo1 pathway","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154766"}}